-
Sector Analysis
Hepatocellular Carcinoma - Epidemiology Forecast to 2029
Hepatocellular carcinoma (HCC) is a common type of primary liver cancer that arises from the hepatocytes in the liver. HCC has a high mortality rate and accounts for 75–90% of all primary liver cancers, making it the third leading cause of cancer mortality worldwide (El-Serag and Rudolph, 2007; Altekruse, McGlynn and Reichman, 2009; Lafaro, Demirjian and Pawlik, 2015; Cancer Treatment Centers of America, 2020). HCC is classified by various staging systems such as the Barcelona Clinic Liver Cancer (BCLC) stage...
-
Product Insights
Vulvar Cancer Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Vulvar Cancer Global Clinical Trials Review, H2, 2018" provides an overview of Vulvar Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Vulvar Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Digital Landscape: Breast Cancer
The Digital Landscape Breast Cancer report analyzes digital activities undertaken by pharma in support of therapies for breast cancer.
-
Product Insights
Anal Cancer Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Anal Cancer Global Clinical Trials Review, H2, 2018" provides an overview of Anal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Anal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Anaplastic Astrocytoma Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Anaplastic Astrocytoma Global Clinical Trials Review, H2, 2018" provides an overview of Anaplastic Astrocytoma clinical trials scenario. This report provides top line data relating to the clinical trials on Anaplastic Astrocytoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H2, 2018" provides an overview of Anaplastic Large Cell Lymphoma (ALCL) clinical trials scenario. This report provides top line data relating to the clinical trials on Anaplastic Large Cell Lymphoma (ALCL). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Anaplastic Oligoastrocytoma Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Anaplastic Oligoastrocytoma Global Clinical Trials Review, H2, 2018" provides an overview of Anaplastic Oligoastrocytoma clinical trials scenario. This report provides top line data relating to the clinical trials on Anaplastic Oligoastrocytoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Anaplastic Thyroid Cancer Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Anaplastic Thyroid Cancer Global Clinical Trials Review, H2, 2018" provides an overview of Anaplastic Thyroid Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Anaplastic Thyroid Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H2, 2018" provides an overview of Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Angiosarcoma Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Angiosarcoma Global Clinical Trials Review, H2, 2018" provides an overview of Angiosarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Angiosarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.